These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24479750)

  • 1. Renal microcirculation and calcium channel subtypes.
    Homma K; Hayashi K; Yamaguchi S; Fujishima S; Hori S; Itoh H
    Curr Hypertens Rev; 2013 Aug; 9(3):182-6. PubMed ID: 24479750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type Ca channel blockade as a determinant of kidney protection.
    Hayashi K; Homma K; Wakino S; Tokuyama H; Sugano N; Saruta T; Itoh H
    Keio J Med; 2010; 59(3):84-95. PubMed ID: 20881449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K; Wakino S; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2005 Nov; 99(3):221-7. PubMed ID: 16293936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
    Hayashi K; Wakino S; Ozawa Y; Homma K; Kanda T; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
    Keio J Med; 2005 Jun; 54(2):102-8. PubMed ID: 16077260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate effects of calcium antagonists on renal microcirculation.
    Hayashi K; Nagahama T; Oka K; Epstein M; Saruta T
    Hypertens Res; 1996 Mar; 19(1):31-6. PubMed ID: 8829821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
    Ogimoto A; Higaki J
    Clin Calcium; 2013 Apr; 23(4):569-74. PubMed ID: 23545747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
    Hayashi K; Ozawa Y; Fujiwara K; Wakino S; Kumagai H; Saruta T
    Am J Nephrol; 2003; 23(4):229-44. PubMed ID: 12840599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG; Li M; Navar LG
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F331-7. PubMed ID: 14583435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension.
    Tomino Y
    Curr Hypertens Rev; 2013 May; 9(2):108-14. PubMed ID: 23971692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent mechanisms of ATP-sensitive K+ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2+ channel-dependent and -independent actions of pinacidil.
    Reslerova M; Loutzenhiser R
    Circ Res; 1995 Dec; 77(6):1114-20. PubMed ID: 7586223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB; Al-Mashhadi RH; Cribbs LL; Skøtt O; Hansen PB
    Kidney Int; 2011 Feb; 79(4):443-51. PubMed ID: 21068717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels.
    Hansen PB; Jensen BL; Andreasen D; Skøtt O
    Circ Res; 2001 Sep; 89(7):630-8. PubMed ID: 11577029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles.
    Konno Y; Kimura K
    Int Heart J; 2008 Nov; 49(6):723-32. PubMed ID: 19075488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.